Who owns the CRISPR THERAPEUTICS trademark?

The CRISPR THERAPEUTICS trademark is owned by CRISPR Therapeutics AG.

What class is the CRISPR THERAPEUTICS trademark registered in?

The CRISPR THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for CRISPR THERAPEUTICS?

The USPTO serial number for CRISPR THERAPEUTICS is 98164704.

What is the registration number for CRISPR THERAPEUTICS?

CRISPR THERAPEUTICS is registered under USPTO registration number 7701013.

CRI

USPTO Trademark Record

REGISTERED

CRISPR THERAPEUTICS

SN 98164704·Reg 7701013·Filed Sep 05, 2023

Owner CRISPR Therapeutics AG

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

CRISPR THERAPEUTICS (Serial No. 98164704), Registration No. 7701013, is a registered US trademark filed on Sep 05, 2023 by CRISPR Therapeutics AG. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: February 25, 2031

Mark Intelligence

CRISPR THERAPEUTICS (Reg. #7701013) is a registered US trademark that has been protecting its owner, CRISPR Therapeutics AG, since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 05, 2023

SERIAL

98164704

REG#

7701013

REGISTERED

Feb 25, 2025

Owner

Applicant

CRISPR Therapeutics AG

Entity

Not Provided

Address

Baarerstrasse 14, ZUG V8, 6300

Country

Attorney

NameTiffany D. Gehrke

Law firm

Tiffany D. Gehrke MARSHALL, GERSTEIN & BORUN LLP

Docket

33324/60081

Address

233 SOUTH WACKER DRIVE, SUITE 6300, CHICAGO, IL 60606, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 05, 2023

Serial Number98164704

Registration No.7701013

Registration DateFeb 25, 2025

Status DateFeb 25, 2025

Published for OppositionJan 07, 2025

Mark TypeStandard characters

Attorney Docket33324/60081

Status DescriptionLive and registered

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jul 22, 2019

First use in commerce: Jul 22, 2019

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

19 events

REGISTERED-PRINCIPAL REGISTER

Feb 25, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 25, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jan 07, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 07, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 01, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 10, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Dec 06, 2024

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Dec 06, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Dec 06, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Dec 06, 2024

EXAMINER'S AMENDMENT ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 07, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 07, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 07, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

May 10, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 10, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 10, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

May 01, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 28, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 08, 2023

NEW APPLICATION ENTERED

CRISPR THERAPEUTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by CRISPR Therapeutics AG

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Tiffany D. Gehrke

Resources

Company